Impact of Disrupted Botulinum Toxin Therapy in Movement Disorders Due to COVID-19 Pandemic
Author(s) -
Koti Neeraja,
Bharath Kumar Surisetti,
Nisha Mol,
Shweta Prasad,
Vikram V. Holla,
Nitish Kamble,
Rohan Mahale,
Pramod Kumar Pal,
Ravi Yadav
Publication year - 2020
Publication title -
annals of indian academy of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.427
H-Index - 31
eISSN - 1998-3549
pISSN - 0972-2327
DOI - 10.4103/aian.aian_573_20
Subject(s) - medicine , pandemic , botulinum toxin , depression (economics) , anxiety , covid-19 , dystonia , health care , telemedicine , intensive care medicine , disease , psychiatry , surgery , economic growth , infectious disease (medical specialty) , economics , macroeconomics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom